Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 106, pseudogene (RNU6-106P) is a non-functional segment of DNA resembling the gene for U6 small nuclear RNA but contains disabling mutations that prevent it from functioning as a normal U6 RNA gene[3][6]. U6 small nuclear RNAs are important RNA components of the spliceosome complex involved in mRNA splicing, but pseudogenes like RNU6-106P do not contribute to this function. Most pseudogenes are considered genetic relics, although recent studies suggest some may play regulatory roles as non-coding RNA transcripts, including competitive endogenous RNA (ceRNA) mechanisms, antisense interactions, or modulation of epigenetic states[4][5]. There is no evidence that RNU6-106P itself is transcribed or plays a functional role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 106, pseudogene (RNU6-106P).